Nebius: Why I'm Pounding The Table (Rating Upgrade)

Q4 revenue grew 547% YoY and ARR came in at $1.25B, topping prior guidance and prompting a 'Strong Buy' upgrade as fundamentals improved. Core EBITDA margins expanded, signaling operational leverage, while management set 2026 targets of $7–9B ARR, $3.2B revenue and a 40% group adjusted EBITDA margin backed by aggressive global expansion. The combination of a large ARR beat, margin improvement and high-growth multi-year guidance materially improves the company’s risk/reward profile for investors.

Analysis

Winners extend beyond NBIS itself: infrastructure suppliers (GPUs, networking, colo) and managed-service integrators will see incremental demand as NBIS scales internationally and pushes enterprise deployments, creating a multi-quarter hardware and services billings tail. Incumbent enterprise software vendors face two second-order hits — margin compression on competitive deals as NBIS leverages scale to undercut total cost of ownership, and channel displacement as customers shift spend toward consumption-based bundles.

Key risks cluster around execution and unit economics rather than headline growth. Rapid geographic expansion usually inflates sales & marketing and CAPEX before revenue from those regions matures; expect visible margin pressure in sequential quarters if hiring, localization, or compliance slow adoption. Near-term catalysts that could re-rate the stock include quarterly retention metrics, localization wins in EMEA/APAC, and any signs of customer concentration easing; negatives that flip the narrative would be elevated churn, rising CAC/LTV ratios, or accelerated investment without commensurate conversion.

Trade implementation should balance event risk with convexity: use calendar and LEAP structures to express directional view while capping downside from near-term volatility. A sector pair trade hedges macro: long NBIS exposure offset by short legacy incumbents with high fixed-cost bases that are sensitive to share loss. Monitor real-time indicators (new bookings cadence, gross retention, incremental gross margin) as triggers to add or trim exposure.

The contrarian angle is that market enthusiasm may be underestimating the scale and cost of turning ARR momentum into durable free cash flow in new markets. If any material portion of margin improvement is one-off (pricing, mix, or cyclical cost savings), multiples will compress quickly as investors refocus on cash conversion. Maintain a tight cadence of diligence on recurring revenue quality and international unit economics before increasing size materially.

Key Decisions for Investors

• Initiate a tactical long NBIS equity position (6–12 month horizon): target sizing 2–3% of liquid equities sleeve, set an initial stop at -20% and plan to take partial profits +50%. Rationale: capture mid-cycle multiple expansion while monitoring retention and billings; downside limited by stop.
• Buy NBIS Jan-2027 call spread (bull call) to express convexity with defined risk: long Jan-2027 1.5x ATM call, short higher strike 2.5x call (net debit). Timeframe 12–18 months; expected payoff if international execution accelerates; max loss is premium paid.
• Pair trade: long NBIS / short ORCL (or similar legacy incumbent) equal dollar exposure over 6–12 months to isolate share-shift vs macro. This reduces macro beta and profits if NBIS takes enterprise share; risk is secular software multiple re-rating that lifts both.
• Volatility play: sell short-dated NBIS implied volatility into the next non-confirmatory quarterly report (30–90 days) with strict hedges — convert to long-dated calls if results beat and IV collapses. Reward from IV collapse; tail risk if guidance surprises negatively.